Status:

NOT_YET_RECRUITING

AUTOANTIBODIES AND SYSTEMIC SCLEROSIS

Lead Sponsor:

IRCCS Ospedale San Raffaele

Conditions:

Understand Pathogenicity of SSc-specific Antibodies in SSc and the Effect of Antibody Blockade in Vitro

Eligibility:

All Genders

18-80 years

Brief Summary

Established in vitro assays, combined with state-of-the-art multi-omics approaches and innovative in vitro experimental models, will gain insights into the mechanistic bases underlying Systemic Sclero...

Eligibility Criteria

Inclusion

  • positivity of autoantibodies

Exclusion

  • pregnant

Key Trial Info

Start Date :

September 1 2024

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2025

Estimated Enrollment :

6 Patients enrolled

Trial Details

Trial ID

NCT06502678

Start Date

September 1 2024

End Date

December 31 2025

Last Update

July 16 2024

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

AUTOANTIBODIES AND SYSTEMIC SCLEROSIS | DecenTrialz